PROJECT

Projects

Summary of Investment Information

Project Number

40237

Company Name

PYRAMID PHARMA LIMITED

Date SPI Disclosed

Dec 6, 2017

Country

Tanzania

Region

Africa

Projected Board Date

Jan 18, 2018

Environmental Category

B - Limited

Status

Active

Last Updated Date

Mar 24, 2019

Department

Regional Industry - MAS Africa

Industry

Health, Education and Life Sciences

Previous Events

Approved : Mar 29, 2018
Signed : May 15, 2018
Invested : Mar 22, 2019

Sector

Other Medical

Project Description

Pyramid Healthcare (the “Company”, or “Group”, or “Pyramid”) is a leading medical consumables and equipment and pharmaceuticals distributor with operations across Sub-Saharan Africa. Pyramid represents internationally renowned manufacturers and provides its clients with full services from importation to in-country servicing with trained technicians. 

 

The Project aims to expand Pyramid’s operations to new markets in Sub-Saharan Africa as well as strengthen Pyramid’s existing operations in Tanzania, Kenya, Uganda, Ethiopia, Rwanda, Mozambique, Nigeria and Ghana to improve access to high quality medical consumables, equipment and pharmaceuticals alongside world-class servicing in these markets.

 

The total project cost is estimated at US$15M. IFC is considering up to US$7.5M equity investment for IFC’s own account .  

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation